Cavium, Inc. (NASDAQ:CAVM) is trading up 71.95% versus 12-month low of 35.90 and stands -6.67% lower from its 1-year peak of $66.14. The consensus price target (PT) of $63.21 means that the market expects Company shares to increase by 3.2% in the short run. The sell-side target prices range from $54 to $70. In the last month the stock has moved in price -5.18%, with a one year change of 7.67%. The last trading session volume compares with the 1.03M average and market worth floats around 4.14B.

Cavium, Inc. (NASDAQ:CAVM) gained 0.75% to reach at the trading price of $61.73 as it is set to release its next quarterly earnings report on February 01, 2017. Cavium, Inc. stock trades in the range of $61.08 to $62.12 before the earnings release. Let’s take a closer look at the current earnings forecast, particularly the things traders should pay close attention to. Earnings per share for the recently concluded quarter is expected to come in at $0.54 a share with $224.49M in revenue.

Cavium, Inc. (CAVM) Future Earnings & History

After upcoming fiscal quarter results, all eyes will be on the prospects for the next reporting quarter. Analysts, on average, forecast Cavium, Inc. to earn $0.52 per share (EPS) on revenue of $224.58M. The EPS consensus range is $0.48-$0.57 on revenue between $230M and $220.49M.

While if we look at the Earnings Track Record, Cavium, Inc. (CAVM) managed to surpass quarterly earnings per share estimates in 0 of the trailing twelve fiscal quarters, and has a positive trend with an average surprise of 0%. Last time the company reported, Cavium, Inc. (CAVM) generated $0.43 in earnings per share, beating the consensus estimate of $0.39. Revenues hit $168.12M in the September 2017 quarter, which was above the consensus $160.61M projection. On the other hand, in the June 2017 quarter the company recorded a net $107.16M revenue with earnings per share of $0.29. Wall Street had anticipated $106.7M and $0.29, respectively. For comparison, there was a revenue of $101.88M and EPS of $0.25 in the March 2016 period.

Cavium, Inc. (NASDAQ:CAVM) Analyst Insights

The buoyancy in the outlook of Cavium, Inc. (CAVM) is getting weaker by the somewhat negative sentiment (2.10 on a 5-point scale) that sell-side analysts have provided concerning it. Brokerage firms on the average advocate the company shares as Hold. Susquehanna has been covering shares of CAVM, so it is most recent view is worth a look. In a research note issued on Jun 16, 2016, analysts at downgraded the stock to Hold from Buy. Another noteworthy analyst activity was recorded on Jun 16, 2016. Downgraded the stock to Hold from Buy.